Table 2.
Disease activity of the study participants.
| CD n (%) |
UC n(%) |
|
|---|---|---|
| Self-reported clinical stage of disease | ||
| Remission | 23 (47.9) | 17 (50) |
| Moderate | 16 (33.3) | 11 (32.4) |
| Active | 15 (31.2) | 6 (17.6) |
| CDAI | ||
| 0 | 17 (35.4) | - |
| 1 | 10 (20.9) | - |
| 2 | 17 (35.4) | - |
| 3 | 4 (8.3) | - |
| Montreal classification | ||
| Age at diagnosis (A1/A2/A3) | 8 (16.7)/36 (75)/4 (8.3) | - |
| Disease location (L1/L2/L3) | 17 (35.4)/7 (14.6)/24 (50) | - |
| Disease behavior (B1/B2/B3) | 21 (43.8)/18 (37.5) /15 (3.2) | - |
| Partial Mayo Score | ||
| 0 | - | 17 (50.0) |
| 1 | - | 0 (0) |
| 2 | - | 11 (32.4) |
| 3 | - | 6 (17.6) |
| Montreal classification | ||
| Disease location (E1/E2/E3) | - | 4 (11.8)/16 (47.0)/14 (41.2) |
| Severity of relapse (S0/S1/S2/S3) | - | 12 (35.3)/10 (29.4)/11 (32.4)/3 (8.8) |